FUM Stock Overview
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management.
Futura Medical plc Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£0.47|
|52 Week High||UK£0.51|
|52 Week Low||UK£0.24|
|1 Month Change||17.98%|
|3 Month Change||3.89%|
|1 Year Change||44.51%|
|3 Year Change||374.00%|
|5 Year Change||97.50%|
|Change since IPO||-33.71%|
Recent News & Updates
We're Keeping An Eye On Futura Medical's (LON:FUM) Cash Burn RateSep 25
Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn SituationMay 10
We're Interested To See How Futura Medical (LON:FUM) Uses Its Cash Hoard To GrowJan 10
What We Learned About Futura Medical's (LON:FUM) CEO CompensationDec 21
|FUM||GB Pharmaceuticals||GB Market|
Return vs Industry: FUM exceeded the UK Pharmaceuticals industry which returned 8% over the past year.
Return vs Market: FUM exceeded the UK Market which returned -9.3% over the past year.
|FUM Average Weekly Movement||5.0%|
|Pharmaceuticals Industry Average Movement||5.3%|
|Market Average Movement||5.7%|
|10% most volatile stocks in GB Market||10.8%|
|10% least volatile stocks in GB Market||2.9%|
Stable Share Price: FUM is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: FUM's weekly volatility (5%) has been stable over the past year.
About the Company
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Futura Medical plc Fundamentals Summary
|FUM fundamental statistics|
Is FUM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|FUM income statement (TTM)|
|Cost of Revenue||UK£0|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.02|
|Net Profit Margin||0.00%|
How did FUM perform over the long term?See historical performance and comparison